Embody CareGLP

About Embody CareGLP

Embody CareGLP (joinem.co) is a compounded GLP-1 telehealth platform founded in 2025, offering semaglutide and tirzepatide at $149 to $299 per month. The platform differentiates with two notable features: a 100% satisfaction refund policy and high ongoing support — both uncommon at this price point.

The satisfaction guarantee is a genuine standout. While most GLP-1 telehealth providers offer no refunds on shipped medications, Embody CareGLP’s policy suggests confidence in their product and willingness to stand behind patient outcomes. This earns them the highest consumer protection score in this tier.

However, the clinical foundation is thin. Provider quality is rated low, cost transparency is low, and the platform includes no lab testing and no dietitian access. The compounded medications have unknown CoA testing status, and pharmacy partners are not publicly disclosed.

There are no Trustpilot reviews and no BBB listing to provide independent validation. The Trustpilot page exists but has no ratings yet. Trust and compliance transparency is rated medium — better than some competitors in this tier but still below the threshold where we’d feel confident recommending the platform.

The combination of a strong refund policy with high support shows patient-centric intent, but the lack of clinical depth and external validation keeps Embody CareGLP in the high caution tier until more data becomes available.

At a Glance